ANGO
HealthcareAngioDynamics, Inc.
$10.60-0.11 (-1.03%)
Prev Close
$10.71
Open
$10.78
High
$10.85
Low
$10.49
Volume
178.3K
Market Cap
$446.0M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at AngioDynamics, Inc. (ANGO) has been mixed between buying and selling, with 3 insider purchases totaling $239.5K and 6 insider sales totaling $244.9K. The most recent insider transaction was by Weiss Lawrence T (SVP, Chief Legal Officer), who purchased $118.1K worth of shares on Oct 21, 2025. AngioDynamics, Inc. operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $446.0M.
Buys (12M)
3
$239.5K
Sells (12M)
6
$244.9K
Net Activity
Net Seller
$5.4K
Active Insiders
8
last 12 mo
ANGO Price Chart
ANGO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 21, 2025↗ | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 10,000 | $11.81 | $118.1K | 0 |
| Oct 13, 2025↗ | Trowbridge Stephen A | EVP and CFO | Buy | 890 | $11.16 | $9.9K | 0 |
| Oct 9, 2025↗ | Clemmer James C | President and CEO | Buy | 10,000 | $11.15 | $111.5K | 0 |
| Jul 19, 2025↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1,779 | $8.76 | $15.6K | 0 |
| Jul 19, 2025↗ | Clemmer James C | President and CEO | Sell | 15,306 | $8.76 | $134.1K | 0 |
| Jul 19, 2025↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 1,263 | $8.76 | $11.1K | 0 |
| Jul 19, 2025↗ | Piccinini Laura | SVP International | Sell | 2,599 | $8.69 | $22.6K | 0 |
| Jul 19, 2025↗ | Trowbridge Stephen A | EVP and CFO | Sell | 3,969 | $8.74 | $34.7K | 0 |
| Jul 17, 2025↗ | Piccinini Laura | SVP International | Sell | 3,074 | $8.74 | $26.9K | 0 |
| Jan 16, 2025↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 4,060 | $12.31 | $50.0K | 0 |
| Oct 8, 2024↗ | Trowbridge Stephen A | EVP and CFO | Buy | 1,700 | $5.86 | $10.0K | 0 |
| Oct 7, 2024↗ | Clemmer James C | President and CEO | Buy | 20,000 | $6.03 | $120.6K | 0 |
| Oct 7, 2024↗ | Nighan Warren JR | SVP Quality and Regulatory | Buy | 868 | $6.09 | $5.3K | 0 |
| Jul 20, 2024↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 754 | $7.13 | $5.4K | 0 |
| Jul 20, 2024↗ | Clemmer James C | President and CEO | Sell | 6,354 | $7.13 | $45.3K | 0 |
| Jul 20, 2024↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 528 | $7.13 | $3.8K | 0 |
| Jul 20, 2024↗ | Piccinini Laura | SVP International | Sell | 1,029 | $7.13 | $7.3K | 0 |
| Jul 20, 2024↗ | Trowbridge Stephen A | EVP and CFO | Sell | 1,384 | $7.13 | $9.9K | 0 |
| Jul 19, 2024↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1,025 | $7.18 | $7.4K | 0 |
| Jul 19, 2024↗ | Clemmer James C | President and CEO | Sell | 8,307 | $7.18 | $59.6K | 0 |
| Jul 19, 2024↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 735 | $7.18 | $5.3K | 0 |
| Jul 19, 2024↗ | Piccinini Laura | SVP International | Sell | 1,983 | $7.18 | $14.2K | 0 |
| Jul 17, 2024↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 2,379 | $7.40 | $17.6K | 0 |
| Jul 17, 2024↗ | Clemmer James C | President and CEO | Sell | 28,730 | $7.40 | $212.6K | 0 |
| Jul 17, 2024↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 1,666 | $7.40 | $12.3K | 0 |
| Jul 17, 2024↗ | Piccinini Laura | SVP International | Sell | 2,485 | $7.40 | $18.4K | 0 |
| Jul 17, 2024↗ | Trowbridge Stephen A | EVP and CFO | Sell | 6,601 | $7.31 | $48.3K | 0 |
| Apr 8, 2024↗ | Clemmer James C | President and CEO | Buy | 10,000 | $6.70 | $67.0K | 0 |
| Jul 20, 2023↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 754 | $8.69 | $6.6K | 0 |
| Jul 20, 2023↗ | Centea Scott | SVP/GM, VIT | Sell | 588 | $8.70 | $5.1K | 0 |
| Jul 20, 2023↗ | Clemmer James C | President and CEO | Sell | 6,354 | $8.69 | $55.2K | 0 |
| Jul 20, 2023↗ | Helsel Dave | SVP Global Operations and R&D | Sell | 697 | $8.69 | $6.1K | 0 |
| Jul 20, 2023↗ | Piccinini Laura | SVP International | Sell | 1,029 | $8.70 | $9.0K | 0 |
| Jul 20, 2023↗ | Trowbridge Stephen A | EVP and CFO | Sell | 1,384 | $8.70 | $12.0K | 0 |
| Jul 19, 2023↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1,404 | $8.92 | $12.5K | 0 |
| Jul 19, 2023↗ | Centea Scott | SVP/GM, VIT | Sell | 1,230 | $8.92 | $11.0K | 0 |
| Jul 19, 2023↗ | Clemmer James C | President and CEO | Sell | 11,379 | $8.92 | $101.5K | 0 |
| Jul 19, 2023↗ | Helsel Dave | SVP Global Operations and R&D | Sell | 1,575 | $8.92 | $14.0K | 0 |
| Jul 19, 2023↗ | Trowbridge Stephen A | EVP and CFO | Sell | 3,159 | $8.92 | $28.2K | 0 |
| Jul 14, 2023↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 875 | $9.61 | $8.4K | 0 |
| Jul 14, 2023↗ | Centea Scott | SVP/GM, VIT | Sell | 868 | $9.60 | $8.3K | 0 |
| Jul 14, 2023↗ | Clemmer James C | President and CEO | Sell | 7,168 | $9.61 | $68.9K | 0 |
| Jul 14, 2023↗ | Helsel Dave | SVP Global Operations and R&D | Sell | 992 | $9.61 | $9.5K | 0 |
| Jul 14, 2023↗ | Trowbridge Stephen A | EVP and CFO | Sell | 1,738 | $9.61 | $16.7K | 0 |
| Jun 1, 2023↗ | Piccinini Laura | SVP International | Sell | 1,400 | $9.64 | $13.5K | 0 |
| Feb 3, 2023↗ | Trowbridge Stephen A | EVP and CFO | Sell | 555 | $13.43 | $7.5K | 0 |
| Feb 1, 2023↗ | ROSENZWEIG RICHARD C | SVP and General Counsel | Sell | 1,137 | $13.36 | $15.2K | 0 |
| Jan 31, 2023↗ | Helsel Dave | SVP Global Operations and R&D | Sell | 4,633 | $12.95 | $60.0K | 0 |
| Oct 12, 2022↗ | Trowbridge Stephen A | EVP and CFO | Buy | 1,083 | $13.82 | $15.0K | 0 |
| Oct 10, 2022↗ | Clemmer James C | President and CEO | Buy | 10,000 | $15.00 | $150.0K | 0 |
ANGO Insider Buying Activity
The following table shows recent insider purchases of AngioDynamics, Inc. (ANGO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 21, 2025↗ | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 10,000 | $11.81 | $118.1K | 0 |
| Oct 13, 2025↗ | Trowbridge Stephen A | EVP and CFO | Buy | 890 | $11.16 | $9.9K | 0 |
| Oct 9, 2025↗ | Clemmer James C | President and CEO | Buy | 10,000 | $11.15 | $111.5K | 0 |
| Oct 8, 2024↗ | Trowbridge Stephen A | EVP and CFO | Buy | 1,700 | $5.86 | $10.0K | 0 |
| Oct 7, 2024↗ | Clemmer James C | President and CEO | Buy | 20,000 | $6.03 | $120.6K | 0 |
| Oct 7, 2024↗ | Nighan Warren JR | SVP Quality and Regulatory | Buy | 868 | $6.09 | $5.3K | 0 |
| Apr 8, 2024↗ | Clemmer James C | President and CEO | Buy | 10,000 | $6.70 | $67.0K | 0 |
| Oct 12, 2022↗ | Trowbridge Stephen A | EVP and CFO | Buy | 1,083 | $13.82 | $15.0K | 0 |
| Oct 10, 2022↗ | Clemmer James C | President and CEO | Buy | 10,000 | $15.00 | $150.0K | 0 |
ANGO Insider Selling Activity
The following table shows recent insider sales of AngioDynamics, Inc. (ANGO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 19, 2025↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1,779 | $8.76 | $15.6K | 0 |
| Jul 19, 2025↗ | Clemmer James C | President and CEO | Sell | 15,306 | $8.76 | $134.1K | 0 |
| Jul 19, 2025↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 1,263 | $8.76 | $11.1K | 0 |
| Jul 19, 2025↗ | Piccinini Laura | SVP International | Sell | 2,599 | $8.69 | $22.6K | 0 |
| Jul 19, 2025↗ | Trowbridge Stephen A | EVP and CFO | Sell | 3,969 | $8.74 | $34.7K | 0 |
| Jul 17, 2025↗ | Piccinini Laura | SVP International | Sell | 3,074 | $8.74 | $26.9K | 0 |
| Jan 16, 2025↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 4,060 | $12.31 | $50.0K | 0 |
| Jul 20, 2024↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 754 | $7.13 | $5.4K | 0 |
| Jul 20, 2024↗ | Clemmer James C | President and CEO | Sell | 6,354 | $7.13 | $45.3K | 0 |
| Jul 20, 2024↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 528 | $7.13 | $3.8K | 0 |
| Jul 20, 2024↗ | Piccinini Laura | SVP International | Sell | 1,029 | $7.13 | $7.3K | 0 |
| Jul 20, 2024↗ | Trowbridge Stephen A | EVP and CFO | Sell | 1,384 | $7.13 | $9.9K | 0 |
| Jul 19, 2024↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1,025 | $7.18 | $7.4K | 0 |
| Jul 19, 2024↗ | Clemmer James C | President and CEO | Sell | 8,307 | $7.18 | $59.6K | 0 |
| Jul 19, 2024↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 735 | $7.18 | $5.3K | 0 |
| Jul 19, 2024↗ | Piccinini Laura | SVP International | Sell | 1,983 | $7.18 | $14.2K | 0 |
| Jul 17, 2024↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 2,379 | $7.40 | $17.6K | 0 |
| Jul 17, 2024↗ | Clemmer James C | President and CEO | Sell | 28,730 | $7.40 | $212.6K | 0 |
| Jul 17, 2024↗ | Nighan Warren JR | SVP Quality and Regulatory | Sell | 1,666 | $7.40 | $12.3K | 0 |
| Jul 17, 2024↗ | Piccinini Laura | SVP International | Sell | 2,485 | $7.40 | $18.4K | 0 |
| Jul 17, 2024↗ | Trowbridge Stephen A | EVP and CFO | Sell | 6,601 | $7.31 | $48.3K | 0 |
| Jul 20, 2023↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 754 | $8.69 | $6.6K | 0 |
| Jul 20, 2023↗ | Centea Scott | SVP/GM, VIT | Sell | 588 | $8.70 | $5.1K | 0 |
| Jul 20, 2023↗ | Clemmer James C | President and CEO | Sell | 6,354 | $8.69 | $55.2K | 0 |
| Jul 20, 2023↗ | Helsel Dave | SVP Global Operations and R&D | Sell | 697 | $8.69 | $6.1K | 0 |
| Jul 20, 2023↗ | Piccinini Laura | SVP International | Sell | 1,029 | $8.70 | $9.0K | 0 |
| Jul 20, 2023↗ | Trowbridge Stephen A | EVP and CFO | Sell | 1,384 | $8.70 | $12.0K | 0 |
| Jul 19, 2023↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1,404 | $8.92 | $12.5K | 0 |
| Jul 19, 2023↗ | Centea Scott | SVP/GM, VIT | Sell | 1,230 | $8.92 | $11.0K | 0 |
| Jul 19, 2023↗ | Clemmer James C | President and CEO | Sell | 11,379 | $8.92 | $101.5K | 0 |
| Jul 19, 2023↗ | Helsel Dave | SVP Global Operations and R&D | Sell | 1,575 | $8.92 | $14.0K | 0 |
| Jul 19, 2023↗ | Trowbridge Stephen A | EVP and CFO | Sell | 3,159 | $8.92 | $28.2K | 0 |
| Jul 14, 2023↗ | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 875 | $9.61 | $8.4K | 0 |
| Jul 14, 2023↗ | Centea Scott | SVP/GM, VIT | Sell | 868 | $9.60 | $8.3K | 0 |
| Jul 14, 2023↗ | Clemmer James C | President and CEO | Sell | 7,168 | $9.61 | $68.9K | 0 |
| Jul 14, 2023↗ | Helsel Dave | SVP Global Operations and R&D | Sell | 992 | $9.61 | $9.5K | 0 |
| Jul 14, 2023↗ | Trowbridge Stephen A | EVP and CFO | Sell | 1,738 | $9.61 | $16.7K | 0 |
| Jun 1, 2023↗ | Piccinini Laura | SVP International | Sell | 1,400 | $9.64 | $13.5K | 0 |
| Feb 3, 2023↗ | Trowbridge Stephen A | EVP and CFO | Sell | 555 | $13.43 | $7.5K | 0 |
| Feb 1, 2023↗ | ROSENZWEIG RICHARD C | SVP and General Counsel | Sell | 1,137 | $13.36 | $15.2K | 0 |
| Jan 31, 2023↗ | Helsel Dave | SVP Global Operations and R&D | Sell | 4,633 | $12.95 | $60.0K | 0 |
ANGO Insiders
Similar Stocks to ANGO
ISRG
Intuitive Surgical, Inc.
$470.59-1.81%
$170.20B
BDX
Becton, Dickinson and Company
$159.66+0.02%
$57.83B
RMD
ResMed Inc.
$231.35-0.45%
$33.92B
MDLN
Medline Inc.
$41.44+0.90%
$33.33B
WST
West Pharmaceutical Services, Inc.
$235.46+1.82%
$16.96B
HOLX
Hologic, Inc.
$75.12-0.13%
$16.77B
COO
The Cooper Companies, Inc.
$69.92-2.04%
$13.64B
MASI
Masimo Corporation
$175.50+0.00%
$9.42B